Welcome to E-Menai

S. 125 ambien cr mg About Migraine Migraine headaches affect an estimated 30 million people in the United States and disproportionately affect women 3 to 1. Kowa's pharmaceutical division is focused on cardiovascular therapeutics, with fiscal year 2008 sales of the company's flagship product, LIVALO® (pitavastatin) totaling . is a specialty pharmaceutical company focused primarily in the area of cardiology. It is focused in the R&D of innovative and patented drug delivery systems as well as innovative pharmaceutical products primarily for oral and topical administration. Food and 125 ambien cr mg Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HCl, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital.